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A substantial body of evidence now indicates that plasminogen activator (PA)'
production is a responsive cellular function that can be modulated within wide limits
by a variety of stimuli, including hormones, inflammatory agents, retinoids, and
oncogenic factors (1-13) . Although enzyme secretion is conspicuously associated with
certain processes, such as tissue remodeling (14, 15) or cell migration (6, 16, 17), which
can be considered to require localized extracellular proteolysis, the full significance of
PA production in vivo and the scope of its hormonal control remain to be defined.
One aspect of interest concerns the modulation ofenzyme synthesis in response to
cell surface stimuli . Studies of several systems have shown that PA production can be
regulated by physiological concentrations of polypeptide hormones (follicle-stimulat-
ing hormone, calcitonin, and vasopressin), whose effects are known to be mediated by
interaction with specific receptors on the external surface of plasma membranes . In
all of the cases so far investigated, enzyme production reflected changes in PA gene
expression occurring in response to hormone-stimulated increases in CAMP levels . It
is also known that specific antibodies directed against cell surface structures can both
mimic polypeptide hormone effects and stimulate processes, such as inflammation
(18) and tumor growth (19-21), that are associated with enhanced PA production . A
particularly well-studied example is the so-called long-acting thyroid stimulator that
is often present in the serum of thyrotoxic patients (22, 23) . This molecule has been
identified as an immunoglobulin (IgG) that reacts with the receptor for thyroid-
stimulating hormone (TSH) and thereby reproduces the effects ofTSH. An additional,
but less well-analyzed example is the reported ability of immunoglobulin-enriched
fractions from sera of pemphigus patients to enhance proteolysis in human keratino-
cyte cultures (24) . The specific receptors that mediate the inflammatory, endocrine,
or tumor-enhancing actions of antisera remain to be identified, but it is established
beyond any doubt that these effects are also due to IgG .
The present studies were undertaken to determine whether specific antibodies
interacting with cell surfaces could modulate PA production, with the following
considerations in mind : (a) assays for PA are sensitive and rapid and might be a
convenient means for detecting antibodies directed against surface constituents, and,
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if this proved to be the case, (b) the PA response to monoclonal antibodies might
ultimately serve to identify a spectrum of surface receptors capable, like hormone
receptors, of mediating transmembrane signalingandactivating intracellular response
systems that regulate gene expression.
Materials and Methods
Materials were purchased from the following sources: fetal bovine serum from Reheis
Chemical Co., Chicago, Ill.; Dulbecco's modified Eagle's medium from Gibco Laboratories,
Grand Island Biological Co., Grand Island, N. Y.; actinomycin D, cycloheximide, colchicine,
soybean trypsin inhibitor, trasylol, leupeptin, and Triton X-100 from SigmaChemical Co., St .
Louis, Mo.; twice-crystallized pepsin from Worthington Biochemical Corp., Freehold, N. J.;
Aquacide IIA and bovine fibrinogen from Calbiochem-Behring Corp., American Hoechst
Corp., San Diego, Calif. ; protein A-Sepharose CL-4B, DEAE-Sepharose from Pharmacia Fine
Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J. Human plasminogen was prepared from
fresh or outdated plasma by the method of Deutsch and Mertz (25). Plasminogen-depleted
serum was prepared as described (16), and fibrinogen was purified accordingto Strickland and
Beers (3). Multiwell culture dishes, model F13 16-24 TC plates were from Linbro Chemical
Co., Hamden, Conn., and tissue culture dishes were from Falcon Labware, Div. of Becton,
Dickinson & Co., Oxnard, Calif. Fibronectin purified from human plasma was a gift from Dr.
M. Furie.
Cell Culture.
￿
LLC-PKI cells (26) were a gift from Dr. J.-D. Vassalli, and KA31 cells (27)
were from Dr. D. B. Rifkin, New York University. HEF-MCA (hamster embryo fibroblasts
transformed by 3-methylcholanthrene) were from Dr. R. J. Pienta, Frederick Cancer Center,
Fort Detrick, Md. TMCK-1 (mouse kidney cells) were obtained from American Type Culture
Collection CCL139, human foreskin fibroblasts were prepared by Dr. B. Hosein, and HEF-
SV40 and acloneof HEp3 (28) (human epidermoid carcinoma) were as described by Ossowski
et al. (12) and Ossowski and Reich (29), respectively.
LLC-PKI and KA31 cells were cloned from mass culture according to the method of Puck
et al. (30) and were routinely grown in Dulbecco's modified Eagle's medium with 10% fetal
bovine serum. For experiments, cells were seeded at 5 X 104 per Linbro well in 0.5 ml medium
containing 10% heat-inactivated fetal bovine serum. After a 24-h incubation at 37°C, the
cultures were washed three timeswith 0.5 ml medium. The cells were then incubated in 0.5 ml
medium containing 5% heat-inactivated and plasminogen-depleted fetal bovine serum. The
IgG in phosphate-buffered saline (PBS) (31) was added to theappropriate wells in volume not
exceeding 100pl.
Immunization ofRabbits and Purification ofIgG.
￿
Cells used to immunize rabbits were grown to
confluency and detached from the culture dishes with 0.25% trypsin in 1 mM EDTA. After
several washes in PBS the cells were resuspended in 0.15 N NaCl . Rabbits immunized with
KA31 were given two intravenous injections weekly for a total of 4 wk, 107 cells per injection,
and they were bled 2 d after the last injection. A total of eight rabbitswere immunized by this
procedure and only three yielded stimulatory antisera. To immunize with LLC-PKI cells, 4 X
106 (per rabbit) were mixed with complete Freund's adjuvant and the antigen was introduced
by intraperitoneal, intramuscular, and subcutaneous routes. 2wk laterthe rabbits were injected
with 2 X 106 cells intraperitoneally without adjuvant, and after an additional week they were
bled. Antisera from all six rabbits that were immunized stimulated PA production when added
to LLC-PKI cells, and the magnitude of stimulation varied in the range of 4- to 30-fold.
Additional immunization did not increase thedegree of stimulation by antisera from rabbits at
thelowerend ofthescale. Preimmunesera were collectedfrom all rabbits before immunization.
All sera were filtered, heat inactivated at 60°C for 30 min, and stored frozen at -20°C. To
purify IgG, 5-10 ml of rabbit preimmune or immune serum was fractionated by ammonium
sulphate (40% saturation at room temperature). The precipitate was dissolved in PBS and
dialyzed against PBS overnight at 4°C. The sample was loaded on a protein A-Sepharose-CL-
4B column equilibrated with PBS, the column was washed extensively with PBS, and the IgG
was eluted with 3 M KCNS in PBS, pH 7.4.
Preparation of(Fab')2 Fragments.
￿
Purified IgG (30 mg) was dialyzed overnight at 4°C againstD. BECKER, L . OSSOWSKI, AND E. REICH 387
0.07 M acetate buffer, pH 4.0, in 0.05 M NaCl . After dialysis, 200 hg of pepsin was added to
20 mg of IgG, and the solution was incubated for 18 h at 37°C ; a portion of IgG (10 mg) was
treated identically, except for addition of pepsin, and served as positive control . Digestion was
stopped by raising the pH of the solution to 7.6 with 1 N NaOH . The digested antibody was
passed over a protein A-Sepharose CL-4B column equilibrated with PBS . The flow-through
that contained F(ab') 2 fragments was dialyzed overnight against PBS and concentrated by
vacuum dialysis, filtered, and stored at -20°C . When analyzed by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), a single band ofMr 100,000 was detected .
Adsorption ofIgG on LLC-PKI Cells.
￿
2 mg ofimmune IgG was mixed with 8 X 107 cells in a
total volume of 2 .5 ml PBS . The mixture was incubated for 30 min on ice . The cells were
pelleted at 1,500 rpm for 15 min, and the supernate was dialyzed overnight against Dulbecco's
medium . A sample of immune IgG that was treated identically, except for incubation with
cells, served as a positive control . The IgG was filtered and used to stimulate PA in LLC-PK I
cells.
Assay ofPA .
￿
To determine extracellular levels of PA, aliquots of conditioned medium were
collected at desired times, centrifuged at 1,000 g for 15 min, and the supernate was assayed as
described by Unkeless et al . (1), using multiwell Linbro dishes coated witht25l-fibrin . The
reaction mixture contained 20,ul of conditioned medium and 2 ttg ofhuman plasminogen in a
total volume of 300 ftl of 0 .1 M Tris HCI, pH 8 .1 .
For determination of cell-associated PA, cultures were washed at the indicated times with 2
X (500 p,l) volumes ofPBS followed by incubation in 500 gl of 0.001 M EDTA in PBS for 10
min at 37°C . The detached cells were pelleted by low speed centrifugation at 1,000 g for 10
min, and the pellets were lysed by adding 300 l,1 per 1 X 10 5 cells of 0.5% Triton X-100 in 0 .1
M Tris HCI, pH 8 .1 . The cell lysates were assayed for protein content and for PA activity as
described above, using 20 ,ttg lysate protein per reaction mixture .
Each experimental point represents an average of two cultures ; the extracellular and cell-
associated PA of each culture were determined by a duplicate measurement in a fibrin plate
assay . The duplicate measurements varied by <5%, and the variation between duplicate
cultures was <15% . In all experiments, PA activity was compared to the activity of a standard
preparation of human urokinase and expressed as Ploug milliunits (mU) per milliliter condi-
tioned medium collected from 105 cells for extracellular activity or as milliunits per 105 cells for
cell-associated activity .
Results
Three cell types were used, of which two were examined in some detail : (a) KA31,
a 3T3 cell transformed by Kirsten sarcoma virus (32), which spontaneously produces
moderate amounts ofPA under ordinary conditions of culture ; (b) LLC-PK,, a strain
derived from normal pig kidney, which produces very little PA under basal conditions
but can be stimulated to high rates ofenzyme synthesis by calcitonin or vasopressin ;2
and HEp-3 clone 9, a derivative of the human epithelial HEp-3 . Suspensions of each
cell type were used to immunize rabbits . Antisera capable of stimulating PA synthesis
in KA31 cultures were obtained from a minority of rabbits and then only after
prolonged immunization-eight booster injections administered over a period of 4
wk . Stimulatory antisera for LLC-PK, cells wee obtained from all rabbits within
relatively short periodsand after few injections of antigen . PA-inducing rabbit antisera
to HEp-3 clone 9 were obtained after two injections during a period of 2 wk .
Stimulation ofPA Production: Time-Course and Dose Response.
￿
Monolayer cultures of
KA31 and LLC-PK, cells were exposed to IgG purified from the respective antisera,
and PA production in both cases was compared with that in control cultures exposed
to IgG isolated from preimmune serum . The results are presented in Fig . 1 : under
2 Dayer, J . M ., J.-D. Vassalli, J . L . Bobbitt, R . N. Hull, E . Reich, and S . M . Krane . 1981 . Calcitonin
stimulates plasminogen activator in porcine renal tubular cells : LLC-PKI .J. Cell Biol. In press .388
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FIG. 1.
￿
Stimulation of PA production; time-course. KA31 cells and LLC-PKI cells were incubated
with 1 mg/ml of specific immune IgG or with the same concentration of preimmune IgG; at
indicated times, medium from two wells was removed for each experimental point, the cells were
detached and lysed, and all samples were frozen. PA content of medium (extracellular activity) and
of cell lysates (cell associated activity) were determined as described in Materials and Methods. A,
immune IgG, extracellular activity; O, immune IgG, cell-associated activity; A, preimmune IgG,
extracellular activity; 0, preimmune IgG, cell-associated activity.
basal conditions, in the presence of preimmune serum, the KA31 cells (Fig. 1 A)
contained readily detectable levels of cell-associated enzyme, but the amounts of PA
secreted into the medium were very low. After the addition of immune IgG, cell-
associated PA rose rapidly; a significant increase was observed within 4 h, reaching a
peak after 8-12 h before dropping offslightly. Secreted enzyme lagged slightly behind,
with the peak levels in conditioned medium being achieved after 24 h. The increase
in PA production over a 24-h period was 13-fold compared with the preimmune IgG-
treated control .
In the LLC-PK, cultures (Fig. I B), the basal levels of both cell-associated and
extracellular PA were low to undetectable in the presence of preimmune IgG. Here,
exposure to immune IgG was followed by a small but detectable increase in both
intra- and extracellular enzyme at 2 h. Secreted PA rose rapidly beginning at 6 h and
continued to do so until 30 h, reaching levels nearly 20-fold higher than the maximum
obtained with KA31 cells. Cell-associated PA increased concurrently but at a lower
rate, indicating that the turnover of the intracellular pool was more rapid than in the
stimulated mouse cultures. In this experiment, PA production by immune IgG was
stimulated ^-30-fold ; in numerous independent experiments, stimulation varied in the
range of 4- to 30-fold.
Under conditions comparable to those used for the experiments in Fig. 1, PA
production in cultures ofHEp-3 clone 9 exposed to immune rabbit IgG was stimulated
^-20-fold above the level in control, preimmune IgG-treated cultures (data not shown) .
The dose-response curves for IgG-stimulated PA production are presented in Fig.
2 . Appreciable stimulation by immune IgG was observed with both KA31 and LLC-
PKl at the lowest concentration (50 Fig/ml) tested. The degree ofstimulation increased
progressively as a function of IgG concentration, reaching a maximum for both cellD . BECKER, L . OSSOWSKI, AND E . REICH
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￿
Stimulation of PA by IgG : dose response . LLC PKI cells and KA31 cells were exposed to
specific immune IgG or preimmune IgG at concentrations of 50 jug to 2 mg/ml . Medium was
collected from all the wells after 24 h of incubation and was assayed for PA content . L, LLC-PK,
cells with immune IgG (0-400) ; O, KA31 cells with immune IgG (0-80) ; A, LLC-PK, cells with
preimmune IgG; 0, KA31 cells with preimmune IgG .
types at about 1 mg/ml . Further increases in IgG levels produced little or no effect on
pig kidney cells, but PA production by the mouse cells showed progressive relative
inhibition as the immune IgG was raised above 1 mg/ml . This effect might be due to
the separate IgG interactions with individual surface elements that modulate the PA
production in opposite directions, respectively ; or, alternatively, the pattern might
result from interaction at a single class of surface receptors whose effects on PA
synthesis, as a function of the degree of complex formation, are inherently biphasic .
Preimmune IgG did not stimulate PA production by either culture throughout the
range of concentrations tested .
Morphological Effects ofAntisera on Target Cells .
￿
Stimulation ofPA synthesis by anti-
LLC-PK, and anti-KA31 IgG was always preceded by morphological alterations of
each cell type . In untreated cell cultures and in cultures treated with preimmune
rabbit IgG, the cells grew as attached monolayers (Fig . 3A and B) . As early as 2 h
after addition of the respective antisera, both KA31 and LLC-PKI cells became
rounded, formed clusters, and ultimately detached from the bottom of the dish (Fig.
3C) . The rapidity and the extent of the morphological change were dose dependent :
the rounding could be seen within 0.5 h at high concentrations ofIgG (1 mg/ml), but
up to 16 h were required at lower levels (50 ltg/ml) . Both cell types remained fully
viable throughout the experiments, as judged by trypan blue exclusion and retention
of plating efficiency .
We attempted to separate the morphological response to antibody from PA
induction by exposing the cultures to a variety of substances . With KA31, neither
colchicine (10-s M) nor fibronectin (<1 mg/ml) prevented the rounding and detach-
ment of cells, and the addition of the protease inhibitors leupeptin (5 X 10-4 M),
soybean trypsin inhibitor (50,ttg/ml), and Trasylol (100 U/ml) likewise did not blockD. BECKER, L. OSSOWSKI, AND E. REICH
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FIG. 4.
￿
Reversibility ofPA induction. LLC-PKi were incubated with 1 mg/mlof immune IgGfor
12 h. After 12 h the cells were pelleted and replated in fresh medium without IgG (O- - -(D,
O-O). The IgG-containing medium was added to fresh, untreated cells (0) . The cells removed
from the original incubation mixture were restimulated with fresh IgG (shown by upward arrow).
Extracellular PA of the various experimental mixtures was determined every 6 h.
the morphological changes, showing that the latter were not due to proteolysis of
either the cell surface or substratum.
PA induction and morphological change were uncoupled by actinomycin D (1 leg/
ml) or cylcoheximide (10 ,ug/ml) . When cultures of either KA31 or LLC-PK1 cells
were exposed to either of these inhibitors concurrently with antibody, the stimulation
of PA synthesis was reduced by >85%, but the morphological change was unaffected.
Reversibility of Morphological Effects and PA Induction.
￿
That both PA induction and
morphological changes are dependent on the continued presence of antibody was
shown by the following experiment . A culture of LLC-PK1 cells was exposed for 12 h
to a concentration of IgG (1 mg/ml) that induced PA synthesis, cell rounding, and
detachment ofthe monolayer. The suspension ofcells and cell clumps was centrifuged,
and the IgG-containing supernatant medium and cell pellet were collected separately.
The cell pellet was replated in fresh, IgG-free medium: all of the cells reattached and
formed a monolayer within 6 h. As seen in Fig. 4 (open circles), PA production
declined at first after the cells were separated from the stimulatory IgG. Immediately
after a second exposure to IgG (at 12 h after replating), the culture responded rapidly
with a burst of PA synthesis. The first IgG-containing medium obtained by centrifu-
gation of the first culture had retained essentially all of the PA stimulatory activity
after exposure to the original cells because it induced a prompt synthesis of PA when
applied to a fresh cell monolayer (open triangles) . Thus, both the PA response and
the morphological changes were fully reversible and required the continued presence
of the stimulatory IgG. Entirely analogous observations were made with KA31 cells
(data not shown) .
Identification of IgG as the Stimulatory Agent.
￿
It appeared possible that the induction
of PA synthesis and morphological changes might have been due to factors contami-
nating the IgG preparations. Tests for proteolytic or fibrinolytic activity using our
standard 1251-fibrin plate (3) and zymographic assays (34) showed no detectable
activity in the purified antibody solution (data not shown) . The IgG fractions obtained
by ammonium sulfate fractionation and adsorption and elution from protein A-
Fic. 3.
￿
Effect of IgG on morphology of LLC-PK, cells. (A) untreated, (B) exposed to 1 mg/ml of
preimmune IgG for 24 h, and (C) exposed to I mg/ml of immune IgG for 24 h.392 INDUCTION OF PLASMINOGEN ACTIVATOR BY ANTIBODIES
TABLE I
Stimulation of PA by Anti-LLC-PK, and Anti-KA31 IgG of Heterologous Target
Cells
* The results show the maximum stimulation ofextracellular PA production obtained
for each IgG preparation within the range of 0.25-2.00 mg/ml . The different types
of target cells were plated at 5 X 10" per Linbro well and incubated at 37°C . 24 h
later, either anti-LLC-PK, or anti-KA31 IgG was added to the cultures, and
conditioned medium was assayed for PA activity after 24 h, as described in Materials
and Methods .
Sepharose consisted of a single Coomassie-stained band, of apparent mol wt of
150,000, in heavily loaded SDS-PAGE . As a further test for the potential contami-
nants, the IgG were isolated by the sequence ofammonium sulfate fractionation and
passage through DEAE-cellulose columns . The IgG prepared in this way appeared
equally pure when examined by SDS-PAGE and were equally active in stimulating
PA production and inducing morphological changes in target cells .
The factors that induced PA production by LLC-PK, cells were reduced by 70%
when a solution containing 2 mg of purified IgG was adsorbed by exposure to a
suspension of8 X 107 pig kidney cells, a result consistent with the expected behavior
of antibodies directed against cell surface constituents .
The fact that indifferent or preimmune rabbit IgG failed to stimulate PA synthesis
indicated that the F, segment was probably not responsible for this activity. A rigorous
confirmation of this expectation was achieved with F(ab')2 fragments prepared from
purified IgG that induced PA production by LLC-PK, cells : the F(ab~2 was almost
equipotent on a molar basis with the native IgG, and both preparations stimulated
enzyme synthesis by 11- and 13-fold, respectively, at a concentration of 6 X 10-s M .
This is further evidence that enzyme induction is determined by the specificity of the
antibody combining site presumably interacting with a surface antigen .
The specificity of PA induction was tested on a series of cell types ostensibly
unrelated to those used as immunizing antigen . The results (Table I) show clearly
that significant stimulation ofPA synthesis was limited to the immunizing cell type
against which the antiserum was directed .
Discussion
Our results support the following conclusions :
(a) IgG can modulate PA production in at least three cell types . The identity of the
Target cells
Cells used for
immunization
PA (mU
Preim-
mune
IgG
UK/ml)*
Immune
IgG
HEF-MCA (hamster) LLC-PK, 35 .1 31 .5
HEF-SV40 (hamster) LLC-PK, 113 .1 101 .8
TMCK (mouse kidney cells) LLC-PK, 193 .1 212 .4
KA31 (BALB/KiS) LLC-PK, 8 .8 16 .7
HEp-3 (human epidermoid carcinoma) LLC-PK, 34 .0 61 .2
Human skin fibroblasts LLC-PK, 127 .8 255 .6
LLC-PK, LLC-PK, 36 .2 260 .6
Human skin fibroblasts KA31 160 .0 381 .0
KA31 KA31 4 .0 162 .2D. BECKER, L. OSSOWSKI, AND E. REICH
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stimulatory molecules as IgG appears to be firmly established by ordinary purification
procedures, by their removal on the specific adsorbent protein A, and by the activity
of the F(ab')2 fragments.
(b) The effect of the antibodies appears to be specific in the sense that stimulation
of PA production was observed only in cell types used as the immunizing antigen and
did not occur in cultures exposed to preimmune serum. These results, and the
retention of full activity by F(ab')2 fragments, exclude the Fc receptor as the mediator
for PA induction.
(c) The PA-inducing IgG interact with antigenic determinants that are exposed at
the cell surface because they are absorbed by cell suspensions under conditions that
exclude endocytosis and metabolic degradation.
(d) Rounding, clustering, and detachment of cells from the substratum similar to
that observed upon addition of anti-LLC-PKI or anti-KA31 IgG to their target cells
has been described with transformed cell lines grown in the presence of high
concentrations of plasminogen (35) with Rous sarcoma virus-transformed chick
embryo fibroblasts treated with the tumor promoter phorbol myristate acetate (36)
and with cells after exposure to specific antisera (37) . The following considerations,
however, suggest that the morphological changes caused by anti-LLC-PKI and anti-
KA31 IgG are not mediated via plasmin, PA, or other proteases: (i) the morphological
changes are observed in media containing heat-inactivated and plasminogen-depleted
serum where they occur with undiminished intensity; (ii) protease inhibitors such as
Leupeptin, soybean trypsin inhibitor, and Trasylol do not prevent the morphological
changes or subsequent cellular detachment; (iii) inhibitors ofmacromolecule synthesis
prevent PA production but do not affect the morphological changes; and (iv)
preparations of anti-LLC-PKI and anti-KA31 IgG, apparently free of any detectable
protease activity, stimulate PA production and induce detachment of the respective
target cells both before and after diisopropylphosphorofluoridate treatment . Whereas
the morphological changes produced by the IgG molecules therefore appear to be
independent of protease action, it is not evident from the data presented here whether
stimulation of PA production and morphological changes are linked in some other
way, and further work will be required to define the relationship between them.
(e) PA production by the pig kidney cells used in this study is known to be induced
by calcitonin and vasopressin.2 Because the levels of enzyme synthesis achieved by
antibody stimulation were in the same range as those produced by some hormones,
one possible explanation of the IgG effect is that the antibodies were interacting with
one or both of these hormone receptors in a manner reminiscent of the long-acting
thyroid stimulator. It is also possible that interactions with other surface antigens can
increase adenyl cyclase activity either specifically or by way of nonspecific membrane
effects, thereby inducing enzyme production. These possibilities can be tested and
resolved by further work. It will be of interest to explore models of autoimmune and
neoplastic conditions to determine whether increases in PA production by target cells
can be correlated with immunological enhancement .
Summary
We have purified the immunoglobulins (IgG) from rabbit antisera raised against
two cell lines-LLC-PKI derived from pig kidney and from Kirsten sarcoma virus-
transformed BALB/3T3-and have studied the effects of the IgG on cultures of the394
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respective target cells . The following observations were made with both cell types : (a)
The addition of purified IgG produced a rapid change in morphology within 2 h .
This consisted of cell rounding, agglutination, and detachment from the surface of
the dish . (b) Beginning -2 h after IgG addition there was a progressive rise in
plasminogen activator production for 24-36 h . (c) Both the morphological change
and the induction of plasminogen activator (PA) synthesis were reversible and
required the continued presence of IgG for their maintenance . The increase in PA
production, but not morphological change, depended on genetic transcription and
translation, being inhibited by actinomycin and/or cycloheximide . (d) These effects
ofIgG were specific : they were not observed with preimmune or indifferent IgG and
occurred only after interaction between an IgG preparation from antisera and the
cells used to generate the particular antiserum . The divalent IgG fragments F(ab')2
retained fully the activities of the native IgG molecules from which they were derived .
Receivedfor publication 15 April 1981 .
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